Preparation, toxicity analysis and in vivo protective effect of PHYLLANTHIN (cas 10351-88-9)-loaded PLGA nanoparticles against CCl4-induced hepatic fibrosis
-
Add time:07/28/2019 Source:sciencedirect.com
Phyllanthin is a well-known hepatoprotective lignin from the plant Phyllanthus amarus (P. amarus). Its limited solubility in water makes is suitable candidate for nanoparticulate drug delivery system which can provide benefits of better absorption as well as increase the loading of the drug in water. The present investigation was carried out to synthesize phyllanthin nanoparticles (Phyll NP's) using poly lactic-co-glycolic acid (PLGA) as a polymer which is one of the most used biocompatible and biodegradable polymeric candidate with sustained drug release potential at desirable doses. The synthesized Phyll NP's were found to be of 187.6 nm ± 5.0 nm in size and were able to entrap 82.8%.± 1.88% of phyllanthin. Moreover, Transmission electron microscopy (TEM) revealed that the Phyll NP's were spherical in shape. Preclinical developmental toxicity of Phyll NP's in zebrafish embryo model. The in vivo anti-fibrotic efficacy of the Phyll NP's was evaluated in carbon tetrachloride (CCl4)-induced model of hepatic fibrosis by studying various biochemical parameters and also by performing masson's trichrome staining of liver tissue sections. Phyllanthin nanoparticles were found to combat CCl4-induced fibrosis and hepatotoxicity and were able to restore normalcy by reducing levels of liver marker enzymes and collagen levels in a dose dependent manner. The results of the present investigation revealed that Phyll NP's were found to possess higher anti-fibrotic effect at low doses due to an increase in aqueous drug loading in form of nanoparticulate system.
We also recommend Trading Suppliers and Manufacturers of PHYLLANTHIN (cas 10351-88-9). Pls Click Website Link as below: cas 10351-88-9 suppliers
Prev:In(III) and Sc(III) based coordination polymers derived from rigid Benzimidazole-5,6-dicarboxylic acid (cas 10351-75-4): Synthesis, crystal structure and catalytic property
Next:Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by PHYLLANTHIN (cas 10351-88-9)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Investigation of anticancer potential of hypoPHYLLANTHIN (cas 10351-88-9) and PHYLLANTHIN (cas 10351-88-9) against breast cancer by in vitro and in vivo methods08/06/2019
- Immobilization mediated enhancement of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus08/05/2019
- Determination of PHYLLANTHIN (cas 10351-88-9) and Gallic Acid In Herbal Hepatoprotective Formulation By TLC-Densitometry Analysis08/04/2019
- Endothelium-independent effects of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) on vascular tension08/03/2019
- Cytotoxic, caspase-3 induction and in vivo hepatoprotective effects of PHYLLANTHIN (cas 10351-88-9), a major constituent of Phyllanthus niruri08/02/2019
- Ameliorative effects of PHYLLANTHIN (cas 10351-88-9) on carbon tetrachloride-induced hepatic oxidative damage in mice08/01/2019
- PHYLLANTHIN (cas 10351-88-9) from Phyllanthus amarus inhibits cellular and humoral immune responses in Balb/C mice07/31/2019
- HPLC fingerprint and simultaneous quantitative analysis of PHYLLANTHIN (cas 10351-88-9) and hypoPHYLLANTHIN (cas 10351-88-9) for identification and authentication of Phyllanthus niruri from related species07/30/2019
- Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by PHYLLANTHIN (cas 10351-88-9)07/29/2019


